These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 26036909)

  • 1. The TLR-2/TLR-6 agonist macrophage-activating lipopeptide-2 augments human NK cell cytotoxicity when PGE2 production by monocytes is inhibited by a COX-2 blocker.
    Müller C; Tufa DM; Chatterjee D; Mühlradt PF; Schmidt RE; Jacobs R
    Cancer Immunol Immunother; 2015 Sep; 64(9):1175-84. PubMed ID: 26036909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Failure of mycoplasma lipoprotein MALP-2 to induce NK cell activation through dendritic cell TLR2.
    Sawahata R; Shime H; Yamazaki S; Inoue N; Akazawa T; Fujimoto Y; Fukase K; Matsumoto M; Seya T
    Microbes Infect; 2011 Apr; 13(4):350-8. PubMed ID: 21172450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toll-like receptor 2/6 agonist macrophage-activating lipopeptide-2 promotes reendothelialization and inhibits neointima formation after vascular injury.
    Grote K; Sonnenschein K; Kapopara PR; Hillmer A; Grothusen C; Salguero G; Kotlarz D; Schuett H; Bavendiek U; Schieffer B
    Arterioscler Thromb Vasc Biol; 2013 Sep; 33(9):2097-104. PubMed ID: 23868938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macrophage-activating lipopeptide-2 (MALP-2) induces a localized inflammatory response in rats resulting in activation of brain sites implicated in fever.
    Knorr C; Hübschle T; Murgott J; Mühlradt P; Gerstberger R; Roth J
    Brain Res; 2008 Apr; 1205():36-46. PubMed ID: 18353287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intratumoural injection of the toll-like receptor-2/6 agonist 'macrophage-activating lipopeptide-2' in patients with pancreatic carcinoma: a phase I/II trial.
    Schmidt J; Welsch T; Jäger D; Mühlradt PF; Büchler MW; Märten A
    Br J Cancer; 2007 Sep; 97(5):598-604. PubMed ID: 17667928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macrophage-activating lipopeptide-2 induces cyclooxygenase-2 and prostaglandin E(2) via toll-like receptor 2 in human placental trophoblast cells.
    Mitsunari M; Yoshida S; Shoji T; Tsukihara S; Iwabe T; Harada T; Terakawa N
    J Reprod Immunol; 2006 Dec; 72(1-2):46-59. PubMed ID: 16600383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stimulation of pulmonary immune responses by the TLR2/6 agonist MALP-2 and effect on melanoma metastasis to the lung.
    Schill T; Schön MP; Pletz N; Emmert S; Schön M
    Exp Dermatol; 2012 Feb; 21(2):91-8. PubMed ID: 22044500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in PGE2 production between primary human monocytes and differentiated macrophages: role of IL-1β and TRIF/IRF3.
    Endo Y; Blinova K; Romantseva T; Golding H; Zaitseva M
    PLoS One; 2014; 9(5):e98517. PubMed ID: 24870145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple protein kinase pathways mediate amplified IL-6 release by human lung fibroblasts co-exposed to nickel and TLR-2 agonist, MALP-2.
    Gao F; Brant KA; Ward RM; Cattley RT; Barchowsky A; Fabisiak JP
    Toxicol Appl Pharmacol; 2010 Sep; 247(2):146-57. PubMed ID: 20600219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthetic mycoplasma-derived lipopeptide MALP-2 induces maturation and function of dendritic cells.
    Weigt H; Mühlradt PF; Emmendörffer A; Krug N; Braun A
    Immunobiology; 2003; 207(3):223-33. PubMed ID: 12777064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TLR2/6 stimulation of the rat lung: effects on lymphocyte subsets, natural killer cells and dendritic cells in different parts of the air-conducting compartments and at different ages.
    Pabst R; Durak D; Roos A; Lührmann A; Tschernig T
    Immunology; 2009 Jan; 126(1):132-9. PubMed ID: 18565128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunostimulation with macrophage-activating lipopeptide-2 increased survival in murine pneumonia.
    Reppe K; Tschernig T; Lührmann A; van Laak V; Grote K; Zemlin MV; Gutbier B; Müller HC; Kursar M; Schütte H; Rosseau S; Pabst R; Suttorp N; Witzenrath M
    Am J Respir Cell Mol Biol; 2009 Apr; 40(4):474-81. PubMed ID: 18931326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of tumor-derived prostaglandin-e2 blocks the induction of myeloid-derived suppressor cells and recovers natural killer cell activity.
    Mao Y; Sarhan D; Steven A; Seliger B; Kiessling R; Lundqvist A
    Clin Cancer Res; 2014 Aug; 20(15):4096-106. PubMed ID: 24907113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beneficial effects of TLR-2/6 ligation in pulmonary bacterial infection and immunization with Pseudomonas aeruginosa.
    Kerber-Momot T; Leemhuis D; Lührmann A; Munder A; Tümmler B; Pabst R; Tschernig T
    Inflammation; 2010 Feb; 33(1):58-64. PubMed ID: 19844782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nickel alterations of TLR2-dependent chemokine profiles in lung fibroblasts are mediated by COX-2.
    Brant KA; Fabisiak JP
    Am J Respir Cell Mol Biol; 2008 May; 38(5):591-9. PubMed ID: 18096868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mycoplasma fermentans MALP-2 induces heme oxygenase-1 expression via mitogen-activated protein kinases and Nrf2 pathways to modulate cyclooxygenase 2 expression in human monocytes.
    Ma X; You X; Zeng Y; He J; Liu L; Deng Z; Jiang C; Wu H; Zhu C; Yu M; Wu Y
    Clin Vaccine Immunol; 2013 Jun; 20(6):827-34. PubMed ID: 23536693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The CySF-L2 factor from dialysable human leucocyte extract activates natural killer cytotoxicity by induction of interferon gamma.
    Doelker I; Anderer FA
    Cancer Immunol Immunother; 1992; 34(5):299-305. PubMed ID: 1540976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of cytokines and chemokines in human monocytes by Mycoplasma fermentans-derived lipoprotein MALP-2.
    Kaufmann A; Mühlradt PF; Gemsa D; Sprenger H
    Infect Immun; 1999 Dec; 67(12):6303-8. PubMed ID: 10569741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cutting edge: preferentially the R-stereoisomer of the mycoplasmal lipopeptide macrophage-activating lipopeptide-2 activates immune cells through a toll-like receptor 2- and MyD88-dependent signaling pathway.
    Takeuchi O; Kaufmann A; Grote K; Kawai T; Hoshino K; Morr M; Mühlradt PF; Akira S
    J Immunol; 2000 Jan; 164(2):554-7. PubMed ID: 10623793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Lipopeptide MALP-2 Promotes Collateral Growth.
    Troidl K; Schubert C; Vlacil AK; Chennupati R; Koch S; Schütt J; Oberoi R; Schaper W; Schmitz-Rixen T; Schieffer B; Grote K
    Cells; 2020 Apr; 9(4):. PubMed ID: 32316253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.